Podcasts about Internal medicine

Jacob Sebaugh is a professional paintball player for PB FIT and Doctor of Internal Medicine. Balancing two highly demanding professions at an elite level, Jacob discusses strategy for managing both professions. He is also the 2025 Rookie Of The Year.JOIN THE DISCORD:https://www.patreon.com/bePatron?u=34554029SHOW SPONSORS:https://www.lonewolfpaintball.com/Support the showJoin the PTG community by clicking the orange

In this episode, Carmela Rocchetti, MD, Director of Human Dimension and Assistant Professor of Internal Medicine at the Hackensack Meridian School of Medicine, joins the podcast to discuss an innovative educational program designed to bring the social determinants of health to life for future healthcare professionals. She shares how teaching the human element of care helps clinicians better understand patients' experiences, build trust, and foster stronger relationships that lead to more compassionate and effective healthcare.

Roger Seheult, MD of MedCram explores two new rooftop ICU facilities and tries out the MiEye light sensor. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on June 9th, 2026) Roger Seheult, MD is the co-founder and lead professor at: www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT:  Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC FOLLOW US ON SOCIAL MEDIA: Facebook:  www.facebook.com/MedCram Twitter/X: www.twitter.com/MedCramVideos Instagram: www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Topic: Heat Illnesses & Hydration Email the show: remedy@mpbonline.org. Hosted on Acast. See acast.com/privacy for more information.

Email the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcastSummer time safety: Drowning, swimming lessons, ear infections, and tick warnings Hosted on Acast. See acast.com/privacy for more information.

Heat hits differently when you're a burn survivor—and this week, we're getting into the science behind why. ☀️Rachel and Amber sit down with Dr. Craig Crandall, Professor of Internal Medicine at UT Southwestern Medical Center and Director of the Thermal and Vascular Physiology Laboratory at Texas Health Presbyterian Hospital Dallas. For over 20 years, Dr. Crandall has been continuously funded by the NIH to study the long-term thermoregulatory and cardiovascular effects of severe burn injuries and he brings all of that expertise to the table in this conversation.We dig into how Dr. Crandall first found his way into burn research, what actually happens in a survivor's body during heat stress, and why heat tolerance looks so different after a burn injury. From there, we walk through the Burn Survivor Heat Risk Calculator—breaking down what each input means (think TBSA, burn location, body weight, activity level, and more) and why it matters for your safety. We also cover cooling strategies, why your heart rate might spike in the heat, and the critical role hydration plays in regulating your body temperature.

Drs Kaniksha Desai and Sara Lubitz discuss secondary hypothyroidism. This podcast is intended for healthcare professionals only. Kaniksha Desai, MD, Associate Professor, Department of Internal Medicine, Endocrinology, Stanford University, Palo Alto, California Sara E. Lubitz, MD, Professor, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey To read a partial transcript or to comment, visit: https://www.medscape.com/index/list_15483_0

Support the Institute today. https://givenow.nova.edu/the-institute-for-neuro-immune-medicine-inim-2025   In today's episode, Haylie Pomroy is joined by Dr. Theoharis Theoharides, one of the world's leading authorities on mast cell biology and neuroimmunology, to reframe multiple chemical sensitivity as a measurable, physiological immune response rooted in mast cell activation. Dr. Theoharides explains how mast cells throughout the body and brain respond to environmental chemicals, stress hormones, fragrances, mold toxins, and other triggers by releasing hundreds of chemical mediators that can affect every organ system simultaneously. He outlines the specific labs and biomarkers worth requesting, why standard diagnostic pathways frequently miss this condition, and what patients can do right now to reduce mast cell reactivity through natural compounds, environmental modifications, and targeted testing. This is a conversation that gives patients the clinical language and tools they need to stop being dismissed and start getting answers. Tune in to Hope and Help For Fatigue and Chronic Illness. Dr. Theoharis Theoharides is a Professor, Vice Chair of Clinical Immunology, and Director at the Institute for Neuro-Immune Medicine-Clearwater, an Adjunct Professor of Immunology at Tufts School of Medicine, where he was a Professor of Pharmacology and Internal Medicine, and also the  Director of Molecular Immunopharmacology & Drug Discovery, and Clinical Pharmacologist at the Massachusetts Drug Formulary Commission (1983-2022). He received his BA, MS, MPhil, PhD, and MD degrees and the Winternitz Price in Pathology from Yale University and received a Certificate in Global Leadership from Tufts Fletcher School of Law and Diplomacy and a Fellowship at Harvard Kennedy  School of Government. He trained in internal medicine at New England Medical Center, which awarded him the Oliver Smith Award, "recognizing excellence, compassion, and service." Dr. Theoharides has 485 publications (46,491 citations; h-index 106), placing him in the world's top 2% of most cited authors, and he was rated the worldwide expert on mast cells by Expertscape. He was inducted into the Alpha Omega Alpha National Medical Honor Society, the Rare Diseases Hall of Fame, and the World Academy of Sciences.   Website: https://www.drtheoharides.com LinkedIn: linkedin.com/in/theoharis-theoharides-ms-phd-md-faaaai-67123735 Instagram: https://www.instagram.com/dr.theoharides/   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Thank you for tuning in to the Hope and Help For Fatigue and Chronic Illness Podcast. Sign up today for our newsletter.

A headline like “weight loss drugs may reduce breast cancer risk” grabs attention fast, but the real story lives in the fine print. We take you through a new Penn Medicine study that observed lower breast cancer rates among women with overweight or obesity who used GLP-1 medications, then we translate what that finding actually means in plain language. Observational data can reveal a signal worth studying, but it cannot prove the medication caused the outcome, and that distinction matters for your decisions and your expectations. We also zoom out to the bigger why: obesity is not just about body size. Fat tissue is biologically active, shaping chronic inflammation, estrogen exposure after menopause, insulin resistance, and even how well the immune system spots abnormal cells. Those pathways help explain why obesity is linked to many cancers, including postmenopausal breast cancer, and why researchers are curious whether effective obesity treatment could shift risk over time. Then we get practical. We review what stronger evidence from randomized controlled trials says so far: GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound do not appear to increase breast cancer risk in the available trial data, even though most trials were not designed to study cancer outcomes for many years. We also discuss why newer studies seem most suggestive for hormone receptor positive breast cancer, along with the leading theories: weight loss itself, improved metabolic health and insulin signaling, reduced inflammation, and the still-unclear possibility of direct GLP-1 effects in cancer biology. If you like evidence-based medicine with real-world context (and a little Philly-life banter), subscribe, share this episode with a friend, and leave a review so more people can find the show. What question do you want answered next about GLP-1s, obesity treatment, or cancer risk?ReferencesRisk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-Analysis. Ko A, Chang YC, Bahar F, et al. Annals of Internal Medicine. 2025;. doi:10.7326/ANNALS-25-02237.Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis. Piccoli GF, Mesquita LA, Stein C, et al. The Journal of Clinical Endocrinology and Metabolism. 2021;106(3):912-921. doi:10.1210/clinem/dgaa891.Glucagon-Like Peptide 1 Receptor Agonists and Cancer Risk: The Good, the Bad and the Unknown. Mannucci E, Dicembrini I. Nature Reviews. Clinical Oncology. 2026;23(6):459-470. doi:10.1038/s41571-026-01135-0.GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women. McDonald ES, Gillis LB, Gabriel P, et al. JCO Oncology Practice. 2026;:101200OP2600485. doi:10.1200/OP-26-00485.GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: A real-world analysis.. Shah Z, Hundal J, Afridi S, et al. Journal of Clinical Oncology. 2026;44(Suppl 16):10548. doi:10.1200/JCO.2026.44.16_suppl.10548.Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer. Tatum KL, Dahman B, Stevenson A, et al. JAMA Network Open. 2026;9(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133.Association of Glucagon-Like Peptide-1 Receptor Agonists With Risk of Cancers-Evidence From a Drug Target Mendelian Randomization and Clinical Trials. Sun Y, Liu Y, Dian Y, et al. International Journal of Surgery (London, England). 2024;110(8):4688-4694. doi:10.1097/JS9.0000000000001514.GLP-1 receptor agonists and breast cancer risk in type 2 diabetes.. Guo Cheng and Amanda Ward. Journal of Clinical Oncology. 2025;43(Suppl 16):10557. doi:10.1200/JCO.2025.43.16_suppl.10557.Glucagon-Like Peptide-1 Analogues and Risk of Breast Cancer in Women With Type 2 Diabetes: Population Based Cohort Study Using the UK Clinical Practice Research Datalink. Hicks BM, Yin H, Yu OH, et al. BMJ (Clinical Research Ed.). 2016;355:i5340. doi:10.1136/bmj.i5340.GLP-1 Receptor Agonists and Cancer: Current Clinical Evidence and Translational Opportunities for Preclinical Research. Valencia-Rincón E, Rai R, Chandra V, Wellberg EA. The Journal of Clinical Investigation. 2025;135(21):e194743. doi:10.1172/JCI194743.Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RNArtwork Rebrand and Avatars:Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qrOriginal Artwork Concept: Olivia Pawlowski

Chrisy and Dr. Kingzett, two women I met when we were all trying to raise our rare voices a little louder. Christine “Chrisy” Klavitter and Dr. Kristen Kingzett are both rare disease advocates, but more importantly, they are people living this reality every single day. Chrisy lives with Stiff Person Syndrome and Myositis. Kristen is an Internal Medicine physician and an ultra-rare cancer survivor. Together, we talk about what life with rare disease actually looks like—beyond the statistics. From delayed diagnoses (which can take years, even decades) to the emotional and physical toll of navigating a fragmented healthcare system, this conversation is honest, eye-opening, and necessary. More than 30 million people in the U.S. are living with a rare disease—defined as affecting fewer than 200,000 people. Yet despite those numbers, patients are still too often misunderstood, misdiagnosed, or left to navigate care on their own. Chrisy and Kristen share what an average day can look like, the full-time job of managing health (or caring for someone who is), and what happens when patients have to push back—even redirect—the so-called experts. We also dig into the bigger questions: Why does diagnosis still take so long—and how do we fix it? What do providers, institutions, and policymakers still not understand? What do you say to someone who believes “there's nothing I can do”? And where are we actually seeing progress in healthcare? What stands out most is this: patients are not passive participants in their care—they are often the ones holding it all together. About my guests: Dr. Kristen Kingzett is an Internal Medicine physician, educator, and advocate who brings both professional expertise and lived experience, including Juvenile Idiopathic Arthritis, Common Variable Immune Deficiency, and an ultra-rare cancer. She serves on Michigan's Rare Disease Advisory Council and Legislative Disability Caucus. Chrisy Klavitter is a healthcare policy and patient advocate, biologist, and recreation therapist. Living with Stiff Person Syndrome and Myositis, she works to bridge communication gaps between patients, providers, researchers, and policymakers to improve care for complex conditions. The takeaway? Rare disease may be defined by numbers, but its impact is anything but small. And if we build a healthcare system that works for rare disease patients, we build one that works better for everyone. Like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredNew: Shop our merchandise! https://thebonnellfoundation.org/product-shop/Thanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/enRead us on Substack: https://substack.com/@lstb?utm_campaign=profile&utm_medium=profile-pageWatch our trailer of Embracing Egypt: https://youtu.be/RYjlB25Cr9Y

Listen Saturday mornings at 8 as Dr. Msonthi Levine discusses medical issues and takes your calls on News Talk 560 KLVI. Dr Levine is board certified in Internal Medicine and Geriatrics. His office is located at 3080 Milam in Beaumont, Texas. He can be reached at 409-347-3621.

This is the audio version of my YouTube video "Harvard Internal Medicine IMG Match Interview | Match Tips from an IMG".You can check the video version ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.➡️ Are you applying to the Match? Check out our match application packages ⁠⁠⁠⁠here⁠⁠⁠⁠.

This episode is deeply personal to me.As the daughter of Indian immigrants, a breast surgeon, and a breast cancer survivor, I've seen firsthand how difficult it can be for our community to talk openly about health issues—especially breast cancer.Too often, conversations are delayed by fear, stigma, modesty, or the belief that we should simply "stay strong" and endure.But when it comes to breast cancer:

Welcome to this week's Midlife Minute. Today, I'm focusing on all the questions I received about gallbladder health, including HRT-provoking symptoms, supplements that improve gallbladder health, and evidence-based food interventions. IN THIS EPISODE, YOU WILL LEARN: Why the risk of gallstones and gallbladder inflammation increases during the menopause transition How estrogen and progesterone HRT have different effects on gallbladder functioning The differences in risk between transdermal and oral HRT How the progesterone in HRT can cause gallbladder issues in some women What TUDCA is, and how it supports gallbladder health The value of TUDCA for women who have had their gallbladders removed How various nutrients and supplements support bile flow and gallbladder health What can contribute to gallstone formation Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Gallbladder Research: Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. Seminars in Liver Disease. 2019;39(4):397–404. doi:10.1055/s-0039-1696799  Vang S, Longley K, Steer CJ, Low WC. The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases. Global Advances in Health and Medicine. 2014;3(3):58–69. doi:10.7453/gahmj.2014.017  Bai M, Yang L, Liao H, et al. Tauroursodeoxycholic acid improves nonalcoholic fatty liver disease by regulating gut microbiota and bile acid metabolism. Journal of Agricultural and Food Chemistry. 2024;72(41):22655–22668. doi:10.1021/acs.jafc.4c04630  Simon JA, Hudes ES. Relation of serum ascorbic acid to serum vitamin B12, serum ferritin, and kidney stones in US adults. *Archives of Internal Medicine.*1999;159(6):619–624. doi:10.1001/archinte.159.6.619  Walcher T, Haenle MM, Kron M, et al. Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterology. 2009;9:74. doi:10.1186/1471-230X-9-74  Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term intake of dietary fiber and decreased risk of cholecystectomy in women. American Journal of Gastroenterology. 2004;99(7):1364–1370. doi:10.1111/j.1572-0241.2004.30281.x  Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology. 2002;123(6):1823–1830. doi:10.1053/gast.2002.37085  Moerman CJ, Smeets FW, Kromhout D. Dietary risk factors for clinically diagnosed gallstones in middle-aged men — a 25-year follow-up study. Annals of Epidemiology. 1994;4(3):248–254. doi:10.1016/1047-2797(94)90099-x Association between dietary magnesium intake and gallstones: the mediating role of atherogenic index of plasma. Lipids in Health and Disease. 2024;23(1):82. doi:10.1186/s12944-024-02074-4  Pitt HA, Doty JE, Murphy MM, Schwarz MB. Progesterone alters biliary flow dynamics. Annals of Surgery. 1999;229(2):205–209. doi:10.1097/00000658-199902000-00008

Email the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Summer time bug bites: mosquitos and ticks Hosted on Acast. See acast.com/privacy for more information.

Send us Fan MailPost-thrombotic syndrome (PTS) affects up to half of patients following deep vein thrombosis and can significantly impair quality of life. Yet treatment options have historically been limited.In this episode of CLOT Conversations, David Airdrie and Dr. Jameel Abdulrehman speak with Dr. Susan Kahn about the recently published C-TRACT trial in The New England Journal of Medicine.The trial evaluated whether endovascular therapy, including iliac vein stenting, could improve outcomes for patients with moderate-to-severe post-thrombotic syndrome and iliac vein obstruction.Dr. Kahn discusses the rationale behind the study, key findings related to symptom burden and quality of life, the increased bleeding risk observed with intervention, practical patient selection considerations, and the unanswered questions that remain regarding long-term management after venous stenting.This episode provides clinicians with practical insights into one of the most important recent studies in the management of post-thrombotic syndrome.Reference:Vedantham S, Kahn SR, Marston WA, Weinberg I, Sista AK, Magnuson EA, Cohen DJ, Wasan SM, Razavi MK, Goldhaber SZ, Sanfilippo KM. Endovascular Therapy for Post-Thrombotic Syndrome—A Randomized Trial. New England Journal of Medicine. 2026 Apr 13.https://www.nejm.org/doi/abs/10.1056/NEJMoa2519001Support the showhttps://thrombosiscanada.caRegister today for our upcoming conference on November 7, 2026 in Montreal at https://thrombosiscanada.ca/2026ConferenceTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

High‑risk MDS and AML continue to challenge clinicians, with limited durable responses and few options for older or treatment‑refractory patients. In this sponsored episode of The Top Line, host Stephanie Butler is joined by Dr. Amer Zeidan, Professor of Internal Medicine at Yale School of Medicine, to unpack new ASCO 2026 data that are drawing attention across the myeloid malignancies field.The discussion focuses on mesutoclax, a novel oral BCL‑2 inhibitor evaluated in combination with azacitidine. Dr. Zeidan breaks down early findings showing a 100% objective response rate with CR rate of 40% per IWG 2006 criteria and 90% composite complete response with CR in 60% in treatment‑naïve high‑risk MDS, along with strong efficacy and encouraging safety signals in AML, with over 80% composite CR, and with potent activity in TP53 mutant, as well as zero death within 30 or 60 days and rapid cytopenia recovery.Listeners will hear how mesutoclax’s potency, selectivity, and pharmacokinetic profile may overcome key limitations of existing BCL‑2 inhibitors, and what these results could mean for future frontline treatment strategies.See omnystudio.com/listener for privacy information.

Addiction affects millions of people, yet it remains one of the most misunderstood and stigmatized medical conditions. This week on SHE MD, Mary Alice Haney sits down with Dr. Sarah Wakeman, a nationally recognized addiction medicine specialist, Harvard Medical School faculty member, and leading advocate for evidence-based addiction treatment.Dr. Wakeman shares how her experiences treating patients revealed a troubling reality: people struggling with addiction are often treated very differently than those with other chronic illnesses. Together, they explore why addiction is a medical condition, not a moral failing, and what needs to change in healthcare, policy, and public perception.The conversation also dives into alcohol use, women's unique health risks, pregnancy, breast cancer, and the growing body of research on how alcohol impacts long-term health. This episode is an eye-opening discussion about stigma, recovery, compassion, and the power of treating addiction with science instead of judgment.Subscribe to SHE MD Podcast for expert tips on PMOS, endometriosis, fertility, hormonal balance, mental health, and more. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.SponsorsKa'Chava: Treat yourself to the flavor and nutrition your body craves. Go to kachava.com and use code SKINNY for 15% off your first order. Use code SHE MD at checkoutOsea: Get 10% off your first order sitewide with code SHEMD at oseamalibu.com. Myriad: Go to GetMyRisk.com to learn more about hereditary cancer testing and how you can use Myriad's virtual care option for fast, at-home testing - no office visit required.Peloton: Let yourself run, lift, sculpt, push and GO. Explore the new Peloton Cross Training Tread+ at onepeloton.comDavid: Buy 4 cartons of Protein Bars and get the 5th free when you go to davidprotein.com/SHEMD.What You'll LearnWhy addiction is a chronic medical conditionHow stigma impacts addiction treatmentWhy women experience alcohol differentlyThe link between alcohol and breast cancerAlcohol's effects during pregnancyCommon myths about addiction recoveryWhat evidence-based addiction care looks likeWhy compassion improves outcomesThe role of trauma in substance use disordersHow to support someone struggling with addictionKey Timestamps00:00 Why Alcohol Is More Dangerous Than Most People Think03:02 What Alcohol Actually Does To Your Brain06:48 Why Some People Become Addicted Faster Than Others10:42 The Science Behind Alcohol Cravings14:56 When Drinking Becomes A Real Problem18:37 Why Addiction Changes Your Brain22:14 Women & Why Alcohol Affects Them Differently26:03 Alcohol, Anxiety & The Sleep Problem30:21 Signs You May Need To Cut Back Drinking37:05 The Best Treatments For Alcohol Use Disorder41:36 New Medications That Reduce Alcohol Cravings44:43 Why Menopause Makes Alcohol Harder To Tolerate45:37 Teens, Alcohol & Parenting Conversations46:42 The Biggest Protective Factors Against Addiction53:05 Why Scare Tactics Fail Teenagers57:39 How To Help Someone With Alcohol Problems58:35 Why Tough Love Usually Doesn't Work01:01:17 Supporting Loved Ones Without Enabling01:07:58 Questions To Ask Yourself About DrinkingKey TakeawaysAddiction should be treated like any other chronic illness, with evidence-based medical care and long-term support.Stigma and judgment often prevent people from getting the treatment they need.Many people with addiction have histories of trauma, adversity, or significant life challenges.Alcohol carries real health risks, including an increased risk of breast cancer, even at lower levels of consumption.Women metabolize alcohol differently and may experience greater health impacts than men.Recovery is possible, especially when treatment is rooted in science, compassion, and individualized care.Language matters; how we talk about addiction can either reinforce stigma or support healing.Understanding addiction as a medical condition is essential to improving care and saving lives.Guest BioDr. Sarah Wakeman is a nationally recognized leader in addiction medicine, a graduate of Brown University, and a faculty member at Harvard Medical School. She is double board-certified in Internal Medicine and Addiction Medicine and serves as the Program Director of the Massachusetts General Hospital Addiction Medicine Fellowship.Throughout her career, Dr. Wakeman has been at the forefront of transforming how substance use disorders are treated, advocating for evidence-based, compassionate care that replaces stigma with science. She has helped develop innovative treatment programs, mentored the next generation of addiction medicine specialists, and worked to expand access to life-saving care for patients across the healthcare system.As a physician, educator, and national thought leader, Dr. Wakeman is passionate about changing the conversation around addiction; helping people understand that substance use disorder is a medical condition, not a moral failing, and that recovery is possible with the right support and treatment.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On the next episode of Redefining Medicine, we are joined by Dr. Melissa Sundermann, also known as "Dr. Outdoors," a board-certified physician in Internal Medicine and Lifestyle Medicine with nearly 30 years of clinical experience. Trained in integrative medicine at the University of Michigan and currently serving as the Medical Director of Lifestyle Medicine for Corewell Health, Dr. Sundermann is passionate about helping patients reconnect with the healing power of nature and lifestyle-based care. In this episode, Dr. Sundermann reflects on why she stepped away from what she calls "factory medicine" - a healthcare model focused on volume, rushed appointments, and symptom-based prescribing. Wanting to build deeper partnerships with her patients, she shifted toward a more personalized, root-cause approach centered on prevention, lifestyle medicine, and long-term wellness. Dr. Sundermann also explores the fascinating science behind phytoncides which are natural compounds emitted by trees and other living green plants. She explains how spending time in nature and inhaling these compounds may help increase natural killer cell activity, strengthen immune function, reduce stress, and support overall health. Don't miss this insightful conversation as Dr. Sundermann shares how lifestyle medicine, nature exposure, and patient-centered care may hold the key to a healthier and more connected future of medicine.

Our trusted source for Methylene Blue: https://www.troscriptions.com/muscle (10% off) Functional medicine Dr. Scott Sherr joins Ben Pakulski to break down methylene blue — the 100-year-old compound that's become one of Ben's favorite tools for energy, focus, and endurance. Dr. Sherr explains how it reboots mitochondrial function in days (not months), how one endurance athlete he coaches cut three hours off a 100-mile race, and how to dose it safely. Plus the warning most people never hear: why the majority of methylene blue sold online is contaminated, and what to look for in a clean source. In this episode… → The bottleneck behind almost everything (energy, brain, recovery, fat loss)  → The four complexes of your electron transport chain, and where most men are blocked → Why statins might be quietly trashing the system you're trying to optimize → Which molecule does "ninja moves" for mitochondrial dysfunction → The exact dosing protocol Scott uses for performance, travel, sauna, and endurance About Dr. Sherr Dr. Scott Sherr is a board-certified Internal Medicine physician and one of the leading clinical voices on methylene blue and mitochondrial medicine. He is certified to practice Health Optimization Medicine (HOMe) — a root-cause framework he helped bring to the U.S. as founder of HOMe-SF, the country's first HOMe clinic — and is a specialist in Hyperbaric Oxygen Therapy (HBOT). He is the COO of Troscriptions (the precision-dosed troche company behind Just Blue, Tro+ Blue, and Blue Cannatine) and its parent, Smarter Not Harder, as well as COO of the nonprofit Health Optimization Medicine and Practice (HOMe/HOPe) USA, which trains doctors to detect and correct the root causes of health. He is also co-founder of OneBase Health, an integrative HBOT ecosystem. He has consulted for Upgrade Labs, Remedy Place, and other wellness ventures, and lives in Louisville, CO with his wife and four kids. Key credentials Board-Certified Internal Medicine Physician  Hyperbaric Oxygen Therapy (HBOT) specialist  COO, Troscriptions / Smarter Not Harder COO, Health Optimization Medicine & Practice (HOMe/HOPe) USA  Co-Founder, OneBase Health  Connect with Dr. Sherr Instagram: https://www.instagram.com/drscottsherr/ LinkedIn: https://www.linkedin.com/in/drsherr Website: https://drscottsherr.com/ Work with Muscle Intelligence The proven system 1000+ men use to stay lean, strong, clear, and capable. https://www.muscleintelligence.com/apply/ If you're interested in working with Ben. ben@muscleintelligence.com Join 200,000 men in their prime, reading our weekly newsletter: http://muscleintelligence.com/newsletter

From Evidence to Action: Incorporating Disability Inclusion in Medical Training and Practice (ICAM 2026) Session Description The ICAM Series | Recorded Live at the International Congress on Academic Medicine (ICAM) What does it take to move disability inclusion from research and policy into everyday medical training and practice? Recorded live at the International Congress on Academic Medicine (ICAM) in Ottawa, Canada, this special episode of the Docs With Disabilities Podcast brings together an extraordinary panel of physician leaders, educators, and advocates working to transform disability inclusion across undergraduate medical education, residency training, and clinical practice. Together, the panel explores how institutions can move beyond awareness and compliance toward meaningful, sustainable change. Drawing from scholarship, systems leadership, and lived experience, they discuss the realities of accommodation implementation, the importance of centralized and trusted systems, faculty training, universal design, and the role of culture in shaping whether disability inclusion succeeds or stalls. This conversation asks difficult—but necessary—questions: How do we create systems that are consistent and humane? How do we support learners and physicians across transitions and career stages? And how do we build medical environments where disability is expected, planned for, and valued? Rich with practical insight and grounded in real-world experience, this live ICAM session highlights a field at an important turning point—one where we increasingly have the evidence, the tools, and the responsibility to act. Whether you are a learner, educator, physician, administrator, or institutional leader, this episode offers concrete ideas and inspiration for advancing disability inclusion within your own environment. Keywords: UGME, PGME, Disability, Learner, Trainee, Medical Education, Policies, Processes, Ableism, Culture, ICAM, AFMC, Docs With Disabilities. Transcript: https://docs.google.com/document/d/18hNrBcylnDfSuT6hJB-RwFMpIBVzEPY21Qf4y0mU0WY/edit?usp=sharing Co-Moderators Lisa Meeks, PhD, MA  Dr. Meeks is a Professor of Medical Education at the University of Illinois College of Medicine in Chicago, IL and holds an appt as an Associate Professor of Family Medicine at the University of Michigan School of Medicine in Ann Arbor, MI. She is the founder of the Docs with Disabilities Initiative and host of the DWDI Podcast. Lynn Ashdown, MD, MMEd   Lynn Ashdown is a patient experience expert who advocates for patients to be included as stakeholders in all levels of healthcare. She has a medical degree, and was close to finishing her residency in family medicine when she began, and continues to navigate, a complex journey as a full-time patient. She has a masters degree in medical education, and presents, participates in research, and is a senior patient partner consulting with various organizations like the Association of Faculties of Medicine of Canada. She's involved in curriculum reform focusing on patient partnerships and is a disability educator within medicine. Lynn is a disability advocate, drawing from her experiences as a patient and person living with multiple disabilities. She's a board member of the Canadian Association of Physicians with Disabilities and is involved with policy and legislative changes to combat ableism and inequities for people living with disabilities. She co-authored Canada's first position statement on the importance of disability inclusion in medical education, and received the 2024 CMA Dr. Ashok Muzumdar Memorial Award for Physicians with Disabilities. Pam Liao, MD, MEd, FRCPC Dr. Liao is the Inaugural Interim Associate Dean Accessibility and Disability Health at the Toronto Metropolitan University School of Medicine. Here, she previously served as the Disability Health Lead and Special Advisor to the Dean at the Toronto Metropolitan University School of Medicine. In her work, she leads efforts to embed critical disability perspectives and anti-ableist practices into medical education. Drawing from her personal experience navigating medical training with a disability, she has dedicated her career to dismantling systemic barriers faced by individuals with disabilities in medicine. Her work includes groundbreaking research—such as the first analysis of accommodations policies in Canadian undergraduate medical programs—and advocacy efforts like the widely recognized "#docswithdisabilities" social media campaign, which brings attention to the underrepresentation of disabled individuals in healthcare and drives meaningful change. She advocated for the establishment of the Association of Faculties of Medicine of Canada (AFMC) Disability Inclusion Network and currently serves as its inaugural Co-Chair. Her advocacy earned her a place on the Board of Directors of the Canadian Association of Physicians with Disabilities, where she continues to serve. Dr. Liao earned her medical degree from the University of British Columbia and completed her residency in Family and Community Medicine and a fellowship in Palliative Medicine at the University of Toronto. She is also an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto and practices clinically in long-term care and rehabilitation settings. Her contributions have been recognized with several honors, including the OMA Section of Palliative Medicine – Award of Excellence. Jill Rudkowski, MD, FRCPC  Dr. Jill Rudkowski is an Associate Professor of Medicine in Department of Medicine (Critical Care) at McMaster University, Hamilton, Ontario, Canada.  She has practised as a critical care physician for over 20 years and is an educator, researcher, and educational leader.  She obtained her MD from the University of Calgary. She trained in Internal Medicine, Respirology, and Critical Care at McGill University after which she completed a Post-doctoral Fellowship with Dr. Barrett Rollins at the Dana-Farber Cancer Institute, Harvard University. She served as Head of Service for the Medical Stepdown Unit and then the Intensive Care Unit at St. Joseph's Healthcare Hamilton for over 10 years.  Dr. Rudkowski has been involved as a co-investigator on numerous patient-focused clinical studies, and these collaborations focus on improving outcomes for survivors of critical illness and the impact on their caregivers. She has designed and delivered curriculum through sessions and workshops on the concept of team compassion in critical care and its role in effective communication.      Dr. Rudkowski has held several educational leadership roles within the McMaster University DeGroote School of Medicine including the Chair of Clerkship and the Director of Student Advising. She is currently the Postgraduate Medicine (PGME) Accommodation Advisor within Resident Affairs and the PGME Resident Assessment Faculty Lead. Dr. Rudkowski has been involved in writing and implementing policy and guidelines around accessing accommodations as well as designing and delivering curriculum aimed at faculty, learners, and administrators through virtual and in person sessions and workshops. Dr. Rudkowski has had the privilege of collaborating nationally and internationally around disability policy in medical education.  She was a member of the Disability Policy Toolkit Committee, Multimedia Resource Hub for Disability Inclusion in Graduate Medical Education on "Learn at ACGME" supported by the 2024 Josiah Macy Jr. Foundation Catalyst Award for Transformation in Graduate Medical Education.  Dr. Rudkowski is currently a member of the Association of Faculties of Medicine of Canada Disability Inclusion and Accessibility Network.  She lives with a chronic disability and is passionate about ensuring that all medical learners and practitioners with disability experience belonging and accessibility in the clinical learning and practice environments.   Camille Munro MD CCFP (PC) Dr. Camille Munro is a palliative medicine physician in the Department of Medicine at the Ottawa Hospital and an Assistant Professor at the University of Ottawa. Originally from Chester, Nova Scotia, she received her Doctor of Medicine from Dalhousie University in 1991 and completed her rotating internship at Royal Columbian Hospital, University of British Columbia. After practicing family medicine in Ottawa for 18 years while raising her children, she returned to the academic setting, driven by a longstanding commitment to compassionate, whole patient-centred care for those facing a serious illness.  In 2018, Dr. Munro was appointed Director of Equity, Diversity and Inclusion for the Department of Medicine where she led initiatives to foster a more inclusive and equitable academic and clinical environment. Her work included the development and implementation of the first formal accommodations policy for physicians with disabilities at a Canadian academic hospital. She remains a strong advocate for physicians with disabilities and for creating environments free from discrimination and inequity. Here work is grounded in compassion, advocacy, and representation; values she brings to her clinical care, teaching, mentorship and leadership. In recognition of her contributions, she received the 2022 Faculty Member Award of Excellence for Leadership in Equity, Diversity, and Inclusion from the University of Ottawa Faculty of Medicine.  Samantha Lavitt, MD Dr. Samantha Lavitt (she/her) is the first Equity, Diversity, and Inclusion Curricular Lead in undergraduate medical education at the University of Ottawa, which sits on the traditional, unceded territory of the Algonquin people. In this role, she designs educational content including topics such as gender equity, sexual orientation and gender diversity, language rights, and disability, integrating these topics throughout the clinical curriculum in a format that connects students with community teachers with lived experience. Trained as a family physician and dedicated to resilience through sustainable practice development, Dr. Lavitt also offers coaching and peer support to family physicians on advocacy, disability, and well-being through the Ontario College of Family Physicians (OCFP). She established the first peer support group for physicians with chronic illness and/or disabilities at the OCFP in 2024 and continues to co-lead this group monthly.  While she finds working with individual physicians and small groups deeply rewarding, this intervention is not enough to dismantle the system of barriers that disabled physicians face in our medical culture, so Dr. Lavitt brings her professional and lived experience as a disabled physician to advocacy initiatives at her academic institution, provincial, and national levels with involvement in peer support projects, webinars, and conference appearances. Produced by: Dr. Lisa Meeks.  Audio editor: Next Day Podcast Digital Media: Lisa Meeks Resources: https://docs.google.com/document/d/1EXw4F1pt5J-O6Y0k-WksDC71RCA6aTFSCOkz-lqJiyc/edit?usp=sharing  

Roger Seheult, MD of MedCram explores the fundamentals of Ebola virus and the best hope for treatment, especially of the BDBV species. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on May 28th, 2026) Roger Seheult, MD is the co-founder and lead professor at: www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT:  Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC FOLLOW US ON SOCIAL MEDIA: Facebook:  www.facebook.com/MedCram Twitter/X: www.twitter.com/MedCramVideos Instagram: www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

Email the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Hosted on Acast. See acast.com/privacy for more information.

LEXINGTON, Ky. (May 28, 2026) – When someone we care about is going through something painful, many of us struggle with the same question: What do I say? On this episode of Behind the Blue, Dr. Abbie Latimer, an assistant professor in the University of Kentucky College of Social Work, talks about hospice and palliative care, serious illness communication and how people can better support one another during difficult moments. Latimer also holds an affiliate appointment in the UK College of Medicine's Department of Internal Medicine, Division of Palliative and Supportive Care.  Before joining the faculty, Latimer worked as a palliative care social worker with UK HealthCare, helping build the inpatient palliative care team and supporting patients, families and care teams through some of life's most difficult conversations. Her current work focuses on research and teaching around serious illness, moral distress, communication and psychosocial care.  Latimer recently spoke at TEDxUKY, where she shared the story of a patient she called "Fred" and explored questions many people face when someone they care about is suffering: What do I say? Why do I sometimes pull away? And how do I find my way back to simply being present? In the conversation, Latimer explains the difference between hospice and palliative care and discusses the broad role social workers play in helping patients and their care systems, including family members, friends, clinicians and community support networks. She also describes why difficult emotions can cause people to reach for familiar phrases such as "hang in there," "stay positive" or "thoughts and prayers," even when those phrases may unintentionally create distance.  Latimer encourages listeners to focus less on finding the perfect words and more on asking open, compassionate questions. Simple prompts such as "Is it okay if we talk about this?" or "What are you most worried about?" can open the door to deeper connection without placing pressure on either person to fix what cannot be fixed.  The episode also explores how silence, presence and listening without an agenda can be meaningful forms of support. Latimer says sometimes the most helpful response is not a solution, but a willingness to sit with someone in the reality of what they are facing. 'Behind the Blue' is available via a variety of podcast providers, including Apple Podcasts, YouTube and Spotify. Subscribe to receive new episodes each week, featuring UK's latest medical breakthroughs, research, artists, writers and the most important news impacting the university. 'Behind the Blue' is a production of the University of Kentucky. Transcripts for most episodes are now embedded in the audio file and can be accessed in many podcast apps during playback. Transcripts for older episodes remain available on the show's blog page.  To discover how the University of Kentucky is advancing our Commonwealth, click here. This interview has been edited for time and clarity.

What does it take to fold a lifelong career in cardiology into one as a successful thriller writer? Dr. Cristina LePort, accomplished cardiologist and Amazon bestselling author, captivates readers with her medical thrillers, which merge her rich medical background with gripping narratives. Cristina's novels, including Dissection, Change of Heart, and Defrosted offer a unique blend of suspense, medical insight, and ethical exploration. Her journey from Italy to the U.S. and transition from medicine to writing highlights her resilience, intellectual curiosity, and dedication to storytelling. Cristina's work stands at the crossroads of medicine and literature, engaging readers with tales that resonate with authenticity and depth. Born in Bologna, Italy, she graduated Summa cum Laude from the University of Bologna, completed her internship and Internal Medicine residency at the Long Island College Hospital in Brooklyn, NY, and her cardiology training at the VA UCLA. She is board-certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology, and is the Chief Medical Officer and co-founder of Genescient, a biotech company devoted to genetic research on aging and longevity. She lives in Corona del Mar, Southern California, with her husband Peter. They have 3 children and 3 grandchildren. Her latest novel is DEFROSTED. Learn more at cristinaleport.com Intro reel, Writing Table Podcast 2024 Outro RecordingFollow the Writing Table: @writingtablepodcastEmail questions or tell us who you'd like us to invite to the Writing Table: writingtablepodcast@gmail.com.

In this episode of Transmission Interrupted, host Jill Morgan sits down with Dr. Gaby Frank, internist and director of the Special Pathogens Center at Johns Hopkins, to provide clarity and insight on the current hantavirus outbreak. The conversation kicks off by demystifying essential public health terms like "isolation" and "quarantine," explaining their definitions and uses in the context of infectious diseases in the U.S. Jill and Dr. Frank then dive into the science behind hantavirus, specifically the unique Andes virus strain in Argentina and its rare but notable potential for human-to-human transmission, a distinction setting it apart from the many other hantavirus strains found throughout the Americas. Listeners will gain a clearer understanding of how hantavirus is typically contracted—primarily from aerosolized rodent droppings rather than person-to-person transmission—and the actual risks associated with exposure. The episode highlights findings from a long-term study in Chile, which revealed only 3.3% of close contacts developed the disease, with greatest risk among household and romantic partners. Jill and Dr. Frank dispel some of the fear and misinformation circulating about hantavirus, stressing that while severe cases can occur, the general public's risk remains very low. Through expert perspective and practical advice, this episode underscores the importance of strategic preparedness and ongoing research, empowering listeners with the knowledge they need to stay safe and informed. Guest Maria (Gaby) Frank, MD, FACP, SFHM Professor of Medicine, PAR, Johns Hopkins University Director, Johns Hopkins Special Pathogens Center Dr. Frank is a hospitalist. Professor of Medicine PAR, and the Director of Johns Hopkins' Special Pathogens Center Johns Hopkins Hospital in Baltimore, MD, one of the 13 Regional Emerging Special Pathogen Treatment Centers (RESPTCs). The Johns Hopkins Hospital (JHH) is a premier 1000-bed non-profit academic medical center within the larger Johns Hopkins Health System, one of the leading health care systems in the United States. The 5-hospital health system in the Baltimore-Washington area has 2513 beds (354 intensive care unit beds) and serves approximately 7 million people. JHH provides a full range of clinical services including specialty care for both adults and pediatric patients. The Johns Hopkins Hospital was ranked number one in the nation by U.S. News & World Report for 22 years of the survey's 30-year history. Before joining Johns Hopkins, Dr. Frank was the Medical Director of the biocontainment unit at Denver Health and Hospital Authority. In her role as the medical director of BCU, she served as the site Principal Investigator for the NIH-sponsored ACTT trial and is actively involved in the National Emerging Special Pathogen Training and Education Center (NETEC) and Special Pathogens Research Network (SPRN). Dr. Frank received her medical diploma from the University of Buenos Aires in Buenos Aires, Argentina, and completed a residency in Internal Medicine and another in Emergency Medicine in Argentina. She immigrated to the U.S. in 2004, where she completed another Internal Medicine Residency at the University of Colorado, joining as faculty after graduation. Her areas of interest include emergent special pathogens, and disaster preparedness and response. Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI). Resources From Mice to Medicine: Exploring Hantavirus and Protecting Healthcare TeamsNETEC Hantavirus InformationSBAR: Andes HantavirusNETEC Webinar Hantavirus Town Hall: Updates for Frontline StaffTransmission Interrupted PodcastNETEC Resource Library About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. For more information visit NETEC on the web at www.netec.org. NETEC Consultation Services Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting. NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert. For more information visit: netec.org/consulting-services.

What roles do data and storytelling play in DEI work? How we can share our perspectives and learn from each other while remaining civil?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Celeste Warren, a DEI consultant and published author. They take a closer look into why it's more important now than ever to continue doing DEI work and the impacts of grounding in the fundamental values of an organization.Celeste Warren is a visionary leader who had an impressive 28-year tenure at a global Fortune 100 company, where she rose to the esteemed position of Vice President and Chief Diversity & Inclusion Officer. During her decade-long leadership of the Global Diversity and Inclusion Center of Excellence, Celeste implemented groundbreaking initiatives that fostered a culture of inclusivity and equity, setting new standards in the industry.Celeste is a published author and her articles on diversity, equity and inclusion have been featured in numerous national and global publications and she has had the opportunity to speak at various events across the world. She has recently published her second book entitled “The Truth About Equity, What It Really Is, What It Isn't and Why Everyone Wins When We Get It Right.”LINKSwww.crwdiversity.com**You can learn more about Dr. Wener's coaching, EFT/Tapping and meditation offerings at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareFollow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Guest(s): Dr. Danny Riche, Clinical Pharmacist at the University of Mississippi Medical CenterTopic: Cholesterol and New Guidelines Follow-UpEmail the show: remedy@mpbonline.org. Hosted on Acast. See acast.com/privacy for more information.

May 22, 2026 ~ Dr. Joel Kammeyer, Associate Professor of Internal Medicine and Chief of Infectious Diseases at Wayne State University, addresses concerns after a plane with a passenger reportedly infected with Ebola was turned away from Detroit. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Why is it so hard to stop eating ultra-processed foods — even when you know they're hurting you? In Episode 13 of this 16-part series, Dr. Brendan McCarthy explains why the real problem is not just the food itself. The real problem is the loop: Cue or emotional state → Wanting → Bargaining → Consumption → Temporary relief → Crash/regret → Repeat. This episode explores how ultra-processed and hyper-palatable foods become attached to stress, boredom, loneliness, exhaustion, anxiety, and emotional discomfort — training the brain to seek relief through food. Key ideas from this episode: • Hunger is the body asking for nourishment • Wanting is the conditioned brain asking for the expected hit • The food is the bait. The loop is the trap. • The food breaks the feeling. It does not heal the source. • You cannot remove a counterfeit regulator without restoring real regulation. Dr. McCarthy breaks down why willpower alone often fails and why lasting change requires a physiologic off-ramp: stable meals, protein, fiber, hydration, sleep, movement, emotional regulation, cue reduction, social planning, and relapse repair. This is not about “perfect eating.” It is about building a life where food is no longer your primary regulator of stress, comfort, or identity. If you've ever felt trapped in cravings, emotional eating, binge-restrict cycles, or constant food noise, this episode is designed to help you understand the mechanism behind the loop — and how to begin leaving it.

Email the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Hosted on Acast. See acast.com/privacy for more information.

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard is joined by Dr. Norman Winn Seay to discuss chronic kidney disease, the connection between obesity and kidney health, and how early awareness, lifestyle changes, and newer medications can help protect kidney function.To learn more about kidney health and chronic kidney disease, explore our lastest article, Why Obesity Matters for Kidney Health.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

What If...What if the reason your weight feels impossible to manage has nothing to do with willpower, discipline, or how hard you are trying? What if the system that was supposed to help you has actually been working against you this whole time, and the missing piece was never the prescription at all? Dr. Meghan Garcia-Webb has been asking that question for years, and what she found will change the way you think about your body, your health, and the stories you have been carrying about both.The Summary & Guest IntroDr. Meghan Garcia-Webb is triple board certified in Internal Medicine, Lifestyle Medicine, and Obesity Medicine, and she runs a first of its kind concierge practice that combines cutting edge weight medicine with life coaching because she knows the prescription is only part of the story. After years of watching the same conversations fail her patients over and over again, she realized that the information was never the problem. The missing piece was always the mindset. In this episode, she and Erica go deep on GLP-1 medications, the one thing blocking most women's results, why the healthcare system has been failing women long before Ozempic hit the headlines, and what it actually takes to build a relationship with food and your body that lasts.Inside the EpisodeThe One Big Thing: It is not your meal plan, your medication, or your macros. Dr. Meghan says the single most important shift women can make is recognizing that they are fully autonomous in their health decisions, even inside a system that was not designed to support them.The System Was Never Built for Us: From childbirth narratives to menopause myths to SSRIs prescribed as a first response to a woman's very reasonable distress, Dr. Meghan breaks down the specific ways women have been mistreated and misled in weight medicine for decades.The Truth About GLP-1 Medications: If you are only hearing the highlight reel about Ozempic and Wegovy, this is the conversation you actually need. Dr. Meghan prescribes these medications every single day and she has things to say about lifelong commitment, wildly varied side effects, and what happens when insurance stops covering them.Why Cortisol, Sleep, and Chronic Stress Are Running the Show: The go-go-go productivity lifestyle that most women in corporate are surviving is not just burning them out. It is biologically working against their ability to maintain a healthy weight. Dr. Meghan explains exactly how and why.Perfectionism and the Fresh Start Trap: Monday diets, January reset plans, the all-or-nothing death spiral. Dr. Meghan names the pattern that keeps women stuck in a cycle of starting over and never actually arriving, and she offers a completely different way to track progress.Untangling Diet Culture: Before any protocol or prescription, Dr. Meghan starts by finding out what each woman is actually carrying, the food rules, the body expectations, the shame she inherited. The work begins there.Give Yourself the Gold Star: Nobody is coming to applaud you for the 10-minute workout, the lunch you actually sat down to eat, or the doctor's appointment you finally scheduled. Dr. Meghan makes the case for why you need to start celebrating yourself now, without anyone else's permission.Resources & Links

Transforming healthcare delivery in resource-limited contexts around the world calls for compassionate, innovative solutions. Learn how The Luke Commission is bringing healthcare to the most isolated and underserved in Eswatini through a scalable model for advancing health equity.

What If...What if the reason your weight feels impossible to manage has nothing to do with willpower, discipline, or how hard you are trying? What if the system that was supposed to help you has actually been working against you this whole time, and the missing piece was never the prescription at all? Dr. Meghan Garcia-Webb has been asking that question for years, and what she found will change the way you think about your body, your health, and the stories you have been carrying about both.The Summary & Guest IntroDr. Meghan Garcia-Webb is triple board certified in Internal Medicine, Lifestyle Medicine, and Obesity Medicine, and she runs a first of its kind concierge practice that combines cutting edge weight medicine with life coaching because she knows the prescription is only part of the story. After years of watching the same conversations fail her patients over and over again, she realized that the information was never the problem. The missing piece was always the mindset. In this episode, she and Erica go deep on GLP-1 medications, the one thing blocking most women's results, why the healthcare system has been failing women long before Ozempic hit the headlines, and what it actually takes to build a relationship with food and your body that lasts.Inside the EpisodeThe One Big Thing: It is not your meal plan, your medication, or your macros. Dr. Meghan says the single most important shift women can make is recognizing that they are fully autonomous in their health decisions, even inside a system that was not designed to support them.The System Was Never Built for Us: From childbirth narratives to menopause myths to SSRIs prescribed as a first response to a woman's very reasonable distress, Dr. Meghan breaks down the specific ways women have been mistreated and misled in weight medicine for decades.The Truth About GLP-1 Medications: If you are only hearing the highlight reel about Ozempic and Wegovy, this is the conversation you actually need. Dr. Meghan prescribes these medications every single day and she has things to say about lifelong commitment, wildly varied side effects, and what happens when insurance stops covering them.Why Cortisol, Sleep, and Chronic Stress Are Running the Show: The go-go-go productivity lifestyle that most women in corporate are surviving is not just burning them out. It is biologically working against their ability to maintain a healthy weight. Dr. Meghan explains exactly how and why.Perfectionism and the Fresh Start Trap: Monday diets, January reset plans, the all-or-nothing death spiral. Dr. Meghan names the pattern that keeps women stuck in a cycle of starting over and never actually arriving, and she offers a completely different way to track progress.Untangling Diet Culture: Before any protocol or prescription, Dr. Meghan starts by finding out what each woman is actually carrying, the food rules, the body expectations, the shame she inherited. The work begins there.Give Yourself the Gold Star: Nobody is coming to applaud you for the 10-minute workout, the lunch you actually sat down to eat, or the doctor's appointment you finally scheduled. Dr. Meghan makes the case for why you need to start celebrating yourself now, without anyone else's permission.Resources & Links

For High Blood Pressure Education Month, our May episode focused on the link between hypertension and high cholesterol, which, together, can significantly raise the risk of heart disease, stroke and other serious illnesses. Our guest Dr. Mary Gover, a general internist at Montefiore Einstein Advanced Care, also shared new cholesterol screening guidelines that have the potential to keep us healthy longer. In our May Key Note, Dr. Gover discusses alternatives to traditional statin treatment that offer more choices for those trying to keep their cholesterol in check.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. Get to know your numbers at 1199SEIUBenefits.org/healthyhearts. Find healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. For more information on the new cholesterol guidelines, visit the American Heart Association website. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents.   Guest Bio Mary Gover, MD, is a general internist with Montefiore Einstein Advanced Care. Dr. Gover received her medical degree from Columbia University Vagelos College of Physicians and Surgeons. She completed her Internal Medicine residency with a focus on primary care at Montefiore Einstein and served as chief resident for that program. Dr. Gover has held leadership roles in medical education and practice administration. Above all else, Dr. Gover is passionate about patient care. She believes not only in the importance of clinical excellence and expertise but also in collaboration and partnership. She is certified in health coaching through Wellcoaches, with the aim of furthering patients' personal health goals and overall wellness.

Did you know women are twice as likely to develop Alzheimer's disease as men, and oestrogen may be a key reason why? In this episode, Dr Lucy Burns and Dr Mary Barson break down the real science behind oestrogen's role in brain health and dementia prevention, why the infamous 2003 WHI study sent doctors running scared for decades, and what the latest evidence actually means for women in midlife. If MHT is not right for you, don't worry, protecting your brain is never a one-trick pony. This is the episode every woman in midlife needs to hear. Research mentioned in this episode: Paganini-Hill A, Henderson VW. Archives of Internal Medicine. 1996 Kim YJ et al. Alzheimer's & Dementia. 2021 Nerattini M et al. Frontiers in Aging Neuroscience. 2023 Cipriano GL et al. International Journal of Molecular Sciences. 2024 Melville NA et al. The Lancet Healthy Longevity. 2025 For more information about Real Life Medicine and our programs and special offers: https://www.rlmedicine.com/ Episode, show notes & transcript https://www.rlmedicine.com/can-hrt-prevent-dementia See omnystudio.com/listener for privacy information.

Email the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Hosted on Acast. See acast.com/privacy for more information.

What is cultural distress? It is a negative response rooted in a cultural conflict where the patient lacks control over their situation. It results in more physiologic effects on the body resulting in allostatic overload. To prevent this, healthcare practitioners must use strategies such as cultural humility to help patients navigate healthcare. Come find the best ways to deliver culturally sensitive care in any setting.

Roger Seheult, MD of MedCram explains the mechanism by which hantavirus kills. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on May 7th, 202 Roger Seheult, MD is the co-founder and lead professor at: www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT:  Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC FOLLOW US ON SOCIAL MEDIA: Facebook:  www.facebook.com/MedCram Twitter/X: www.twitter.com/MedCramVideos Instagram: www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/VXA865. CME/AAPA credit will be available until May 15, 2027.Hidden in Plain Sight: Recognizing and Referring Patients With Transthyretin Cardiac Amyloidosis in Internal Medicine In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/VXA865. CME/AAPA credit will be available until May 15, 2027.Hidden in Plain Sight: Recognizing and Referring Patients With Transthyretin Cardiac Amyloidosis in Internal Medicine In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/VXA865. CME/AAPA credit will be available until May 15, 2027.Hidden in Plain Sight: Recognizing and Referring Patients With Transthyretin Cardiac Amyloidosis in Internal Medicine In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

What is the Prisoner Visitation and Support organization?What are some of the issues impacting trans prisoners in this political time?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews two Prisoner Visitation and Support board members, whose mission is to provide inmates of federal prisons with visitors. They discussed self-care when helping people navigate a system that can cause harm.Shazad Carbaidwala is a catalyst for transformation, a former professional bodybuilder leveraging his journey from speaker, Prisoner visitation and support board member, author, project manager, entrepreneur/business owner, humanitarian, coach, and law enforcement official to empower individuals worldwide. Central to his life's mission is the art of helping people in any capacity, where Shazad's impact is felt most profoundly.Linda Roberts discovered the non-profit organization Prisoner Visitation and Support (PVS) and has been visiting predominantly transgender inmates monthly at the Coleman Federal Correctional Complex in Coleman, FL for over 4 years. Recognizing her background, she currently serves as Treasurer and Board member of that organization.LINKSwww.prisonervisitation.org**You can learn more about Dr. Wener's coaching, EFT/Tapping and meditation offerings at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareFollow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/VXA865. CME/AAPA credit will be available until May 15, 2027.Hidden in Plain Sight: Recognizing and Referring Patients With Transthyretin Cardiac Amyloidosis in Internal Medicine In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Roger Seheult, MD of MedCram explores the deadly Andes hantavirus outbreak on the MV Hondius Cruise Ship. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on May 4th, 2026) Roger Seheult, MD is the co-founder and lead professor at: www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT:  Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC FOLLOW US ON SOCIAL MEDIA: Facebook:  www.facebook.com/MedCram Twitter/X: www.twitter.com/MedCramVideos Instagram: www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

Roger Seheult, MD of MedCram explores the connection between hantavirus and interferon. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on May 6th, 2026) Roger Seheult, MD is the co-founder and lead professor at: www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT:  Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred Edited by Daphne Sprinkle of Sprinkle Media Consulting, LLC FOLLOW US ON SOCIAL MEDIA: Facebook:  www.facebook.com/MedCram Twitter/X: www.twitter.com/MedCramVideos Instagram: www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

Host: Jasmine T. Kency, M.D., Associate Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.Topic: Maternal Mental Health Guest: Britney Washington, Certified DoulaEmail the show any time remedy@mpbonline.org. Hosted on Acast. See acast.com/privacy for more information.

Email the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Hosted on Acast. See acast.com/privacy for more information.

Bio: In this episode we speak with Dr. Julianna Lindsey about what it really means to “turn back the clock” on aging, why your blood work may be telling a very incomplete story, and how simple daily habits—from sleep and nutrition to mindset and movement—can dramatically change how you feel and function at any stage of life. Dr. Julianna Lindsey is Board Certified in Internal Medicine with additional training and certifications in anti-aging and regenerative medicine, functional and integrative medicine, lifestyle medicine, bioidentical hormone optimization, and peptide therapy. In addition to her clinical work, she has spent the past fifteen years serving executive leadership roles at Fortune-level companies. During this time, she observed the dysfunction of our health care system on a large scale, an experience that contributed to her motivation in establishing her Radiant Longevity clinic in Southlake, Texas, where she dedicates her life to serving people through personalized care and attention. She is the author of Radiant Longevity: A Physician's Protocol for Living Your Best Life Learning Points Why ‘normal' is not the same as optimal Why longevity is built through small, consistent daily habits Why you have more control over aging than you think WEBSITE: Radiantlongevity.com SOCIAL MEDIA: https://www.linkedin.com/in/juliannalindseymd/ https://www.instagram.com/juliannalindseymd/ Facebook.com/Julianna.lindsey